Medicine & Life Sciences
Triple Negative Breast Neoplasms
100%
Chimeric Antigen Receptors
96%
B-Cell Lymphoma
85%
Whole Genome Sequencing
64%
Genome-Wide Association Study
63%
Neoadjuvant Therapy
59%
Lung Neoplasms
54%
T-Lymphocytes
49%
Survival
47%
Cell- and Tissue-Based Therapy
47%
Genome
45%
Colorectal Neoplasms
43%
Drug Therapy
42%
Data Curation
41%
Statistics
40%
Metastasectomy
39%
Tumor-Infiltrating Lymphocytes
38%
Adenocarcinoma
37%
Neoplasms
36%
Genes
36%
Genetic Association Studies
31%
Phenotype
30%
CD19 Antigens
30%
Computer Simulation
29%
mirvetuximab soravtansine
29%
Confidence Intervals
27%
Precision Medicine
27%
hematopoietic progenitor kinase 1
26%
Odds Ratio
26%
Datasets
25%
Tumor Microenvironment
24%
Cetuximab
24%
Therapeutics
23%
Folate Receptor 1
22%
Meta-Analysis
22%
Hepatocellular Carcinoma
22%
Lipids
22%
Lead
22%
atezolizumab
21%
Circulating Tumor DNA
21%
Molecular Epidemiology
21%
130-nm albumin-bound paclitaxel
21%
Breast Neoplasms
21%
PCI 32765
20%
Cell-Free Nucleic Acids
20%
Immunotherapy
19%
Progression-Free Survival
19%
Ipilimumab
19%
Nivolumab
18%
Mathematics
Genetic Association
45%
Testing
26%
Statistic
24%
Regression Analysis
22%
Gene-environment Interaction
22%
Gene
20%
Breast Cancer
20%
Interval-censored Data
20%
Single nucleotide Polymorphism
19%
Proportional Odds Model
19%
Recurrent Events
18%
Failure Time Data
17%
Surrogate
16%
Misspecification
16%
Cancer
15%
Failure Time
15%
Genome
15%
Maximum Likelihood Estimation
15%
Alternatives
14%
Mixed Data
13%
Interval
13%
Target
11%
Phenotype
11%
Quantitative Trait Loci
11%
Interaction
9%
Genomics
9%
Boundary Detection
9%
Transcription Factor
8%
Regression Coefficient
8%
Growth Hormone
8%
Lung Cancer
7%
Regression Model
7%
Radiation Therapy
7%
Gene Expression
6%
Deficiency
6%
Differential Expression
6%
Simulation Study
6%
Panel Data
5%
Proportional Hazards
5%
Proportional Hazards Model
5%
Estrogen Receptor
5%